Similarly, the tumor suppressor p53 exhibits a dual nature: loss-of-function mutations in cancer disrupt cell-cycle arrest and apoptosis, promoting tumorigenesis, whereas excessive activation of p53 in neurons induces apoptosis and synaptic dysfunction [107,108,109]. This evidence concerns the gene TP53 and cancer.